BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: McElvaney OJ, O'Connor E, McEvoy NL, Fraughan DD, Clarke J, McElvaney OF, Gunaratnam C, O'Rourke J, Curley GF, McElvaney NG. Alpha-1 antitrypsin for cystic fibrosis complicated by severe cytokinemic COVID-19. J Cyst Fibros 2021;20:31-5. [PMID: 33288475 DOI: 10.1016/j.jcf.2020.11.012] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 O'Brien ME, Murray G, Gogoi D, Yusuf A, McCarthy C, Wormald MR, Casey M, Gabillard-Lefort C, McElvaney NG, Reeves EP. A Review of Alpha-1 Antitrypsin Binding Partners for Immune Regulation and Potential Therapeutic Application. Int J Mol Sci 2022;23:2441. [PMID: 35269582 DOI: 10.3390/ijms23052441] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
2 Yang C, Zhao H, Tebbutt SJ. Leave no one behind: inclusion of alpha-1 antitrypsin deficiency patients in COVID-19 vaccine trials. Eur J Hum Genet 2022. [PMID: 35087186 DOI: 10.1038/s41431-022-01047-4] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Di Sarno V, Lauro G, Musella S, Ciaglia T, Vestuto V, Sala M, Scala MC, Smaldone G, Di Matteo F, Novi S, Tecce MF, Moltedo O, Bifulco G, Campiglia P, Gomez-Monterrey IM, Snoeck R, Andrei G, Ostacolo C, Bertamino A. Identification of a dual acting SARS-CoV-2 proteases inhibitor through in silico design and step-by-step biological characterization. Eur J Med Chem 2021;226:113863. [PMID: 34571172 DOI: 10.1016/j.ejmech.2021.113863] [Reference Citation Analysis]
4 Burster T, Mustafa Z, Myrzakhmetova D, Zhanapiya A, Zimecki M. Hindrance of the Proteolytic Activity of Neutrophil-Derived Serine Proteases by Serine Protease Inhibitors as a Management of Cardiovascular Diseases and Chronic Inflammation. Front Chem 2021;9:784003. [PMID: 34869231 DOI: 10.3389/fchem.2021.784003] [Reference Citation Analysis]
5 Williamson M, Casey M, Gabillard-Lefort C, Alharbi A, Teo YQJ, McElvaney NG, Reeves EP. Current evidence on the effect of highly effective CFTR modulation on interleukin-8 in cystic fibrosis. Expert Rev Respir Med 2021;:1-14. [PMID: 34726115 DOI: 10.1080/17476348.2021.2001333] [Reference Citation Analysis]
6 Vianello A, Guarnieri G, Braccioni F, Molena B, Lococo S, Achille A, Lionello F, Salviati L, Caminati M, Senna G. Correlation between α1-Antitrypsin Deficiency and SARS-CoV-2 Infection: Epidemiological Data and Pathogenetic Hypotheses. J Clin Med 2021;10:4493. [PMID: 34640510 DOI: 10.3390/jcm10194493] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Flume PA, Castellani C, Davies J. JCF Year in Review. J Cyst Fibros 2021;20:1-2. [PMID: 33526211 DOI: 10.1016/j.jcf.2021.01.004] [Reference Citation Analysis]